277 related articles for article (PubMed ID: 7916899)
1. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
Brunton VG; Carlin S; Workman P
Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
Reddy KB; Mangold GL; Tandon AK; Yoneda T; Mundy GR; Zilberstein A; Osborne CK
Cancer Res; 1992 Jul; 52(13):3636-41. PubMed ID: 1617636
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
Sion-Vardy N; Vardy D; Rodeck U; Kari C; Levin RM; Malkowicz SB
J Surg Res; 1995 Dec; 59(6):675-80. PubMed ID: 8538164
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the cytoskeletal organization in tumor cell lines by a cardiotonic drug, vesnarinone, through protein tyrosine phosphorylation.
Yoshinaka Y; Katoh I; Kyushiki H; Sakamoto Y
Exp Cell Res; 1995 Jul; 219(1):21-8. PubMed ID: 7543053
[TBL] [Abstract][Full Text] [Related]
5. Regulation of TGF-alpha expression in human keratinocytes: PKC-dependent and -independent pathways.
Klein SB; Fisher GJ; Jensen TC; Mendelsohn J; Voorhees JJ; Elder JT
J Cell Physiol; 1992 May; 151(2):326-36. PubMed ID: 1572907
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation.
Schmidt-Ullrich RK; Mikkelsen RB; Dent P; Todd DG; Valerie K; Kavanagh BD; Contessa JN; Rorrer WK; Chen PB
Oncogene; 1997 Sep; 15(10):1191-7. PubMed ID: 9294612
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of EGF-induced vasoconstriction in isolated rabbit aortic rings with the tyrosine kinase inhibitor RG50864.
Merkel LA; Rivera LM; Colussi DJ; Perrone MH
Biochem Biophys Res Commun; 1993 May; 192(3):1319-26. PubMed ID: 7685166
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity.
Gulli LF; Palmer KC; Chen YQ; Reddy KB
Cell Growth Differ; 1996 Feb; 7(2):173-8. PubMed ID: 8822200
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of a series of tyrphostins containing nitrothiophene moieties as possible epidermal growth factor receptor tyrosine kinase inhibitors.
Brunton VG; Kelland LR; Lear MJ; Montgomery GJ; Robertson JH; Robins DJ; Queen J; Workman P
Anticancer Drug Des; 1996 Jun; 11(4):265-95. PubMed ID: 8679052
[TBL] [Abstract][Full Text] [Related]
10. The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice.
Yoneda T; Lyall RM; Alsina MM; Persons PE; Spada AP; Levitzki A; Zilberstein A; Mundy GR
Cancer Res; 1991 Aug; 51(16):4430-5. PubMed ID: 1651159
[TBL] [Abstract][Full Text] [Related]
11. Effect of tyrphostin on cell growth and tyrosine kinase activity of epidermal growth factor receptor in human gliomas.
Miyaji K; Tani E; Shindo H; Nakano A; Tokunaga T
J Neurosurg; 1994 Sep; 81(3):411-9. PubMed ID: 8057149
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
13. Comparison of protein phosphorylations in variant A431 cells with different growth responses to epidermal growth factor.
Buss JE; Chouvet C; Gill GN
J Cell Physiol; 1984 Jun; 119(3):296-306. PubMed ID: 6202705
[TBL] [Abstract][Full Text] [Related]
14. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
[TBL] [Abstract][Full Text] [Related]
16. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
Gardner DP; Shimizu N
J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
[TBL] [Abstract][Full Text] [Related]
17. Augmented desensitization to epidermal growth factor (EGF) immediate actions: a novel mechanism for altered EGF growth response in mutant A431 cells.
Karasik A; Reddy SS; Pepinsky RB; Brock T; Kahn CR
J Cell Physiol; 1990 Feb; 142(2):231-5. PubMed ID: 1689316
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of epidermal growth factor-stimulated EGF receptor tyrosine kinase activity in A431 human epidermoid carcinoma cells by polyamines.
Faaland CA; Laskin JD; Thomas TJ
Cell Growth Differ; 1995 Feb; 6(2):115-21. PubMed ID: 7756170
[TBL] [Abstract][Full Text] [Related]
19. Actin polymerization localizes to the activated epidermal growth factor receptor in the plasma membrane, independent of the cytosolic free calcium transient.
Rijken PJ; Post SM; Hage WJ; van Bergen en Henegouwen PM; Verkleij AJ; Boonstra J
Exp Cell Res; 1995 May; 218(1):223-32. PubMed ID: 7737361
[TBL] [Abstract][Full Text] [Related]
20. Cytoskeletal and morphological changes associated with the specific suppression of the epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid carcinoma.
Nelson JM; Fry DW
Exp Cell Res; 1997 Jun; 233(2):383-90. PubMed ID: 9194500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]